Cencora Inc. (COR)vsEDAP TMS SA (EDAP)
COR
Cencora Inc.
$325.08
-0.67%
HEALTHCARE · Cap: $63.59B
EDAP
EDAP TMS SA
$3.91
+4.83%
HEALTHCARE · Cap: $134.99M
Smart Verdict
WallStSmart Research — data-driven comparison
Cencora Inc. generates 510539% more annual revenue ($325.78B vs $63.80M). COR leads profitability with a 0.5% profit margin vs -30.8%. COR appears more attractively valued with a PEG of 0.78. COR earns a higher WallStSmart Score of 62/100 (C+).
COR
Buy62
out of 100
Grade: C+
EDAP
Avoid23
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-43.9%
Fair Value
$254.20
Current Price
$325.08
$70.88 premium
Intrinsic value data unavailable for EDAP.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Every $100 of equity generates 134 in profit
Large-cap with strong market position
Growing faster than its price suggests
No standout strengths identified
Areas to Watch
Premium valuation, high expectations priced in
0.5% margin — thin
Operating margin of 1.2%
Trading at 33.1x book value
Smaller company, higher risk/reward
Expensive relative to growth rate
ROE of -59.5% — below average capital efficiency
Earnings declined 62.2%
Comparative Analysis Report
WallStSmart ResearchBull Case : COR
The strongest argument for COR centers on Return on Equity, Market Cap, PEG Ratio. PEG of 0.78 suggests the stock is reasonably priced for its growth.
Bull Case : EDAP
EDAP has a balanced fundamental profile.
Bear Case : COR
The primary concerns for COR are P/E Ratio, Profit Margin, Operating Margin. Thin 0.5% margins leave little buffer for downturns.
Bear Case : EDAP
The primary concerns for EDAP are Market Cap, PEG Ratio, Return on Equity.
Key Dynamics to Monitor
COR profiles as a value stock while EDAP is a turnaround play — different risk/reward profiles.
COR carries more volatility with a beta of 0.65 — expect wider price swings.
EDAP is growing revenue faster at 6.0% — sustainability is the question.
EDAP generates stronger free cash flow (-4M), providing more financial flexibility.
Bottom Line
COR scores higher overall (62/100 vs 23/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Cencora Inc.
HEALTHCARE · MEDICAL DISTRIBUTION · USA
CoreSite Realty Corporation (NYSE: COR) delivers secure, reliable, high-performance data center, cloud access and interconnect solutions to a growing client ecosystem in eight key North American markets.
EDAP TMS SA
HEALTHCARE · MEDICAL DISTRIBUTION · USA
EDAP TMS SA, develops, produces, markets, distributes and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States and internationally. The company is headquartered in Lyon, France.
Compare with Other MEDICAL DISTRIBUTION Stocks
Want to dig deeper into these stocks?